MetaCap

cbdMD Inc. (YCBD)

NYSE: YCBDConsumer DiscretionaryPackage Goods/CosmeticsUSD

0.36-0.0194 (-5.11%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

YCBD stock chart

Technical analysis

Key statistics

All statistics
52-week range
0.33 – 2.56
Day range
0.3425 – 0.3688
Volume / Avg
121.30K / 398.45K
Beta
—
Next earnings
Dec 18, 2026

52-week range

$0.33$2.56

YCBD stock today

Shares of cbdMD (YCBD) finished lower on Nov 20 at $0.36, a drop of 5.11% or $0.0194 per share, versus the S&P 500's 3.70% decline. Trading was light, with 121.30K shares changing hands, about 30% of the average daily volume. At this level, YCBD sits near the bottom of its 52-week range of $0.33 to $2.56: 85.9% below the high and 9.1% above the low.

At 1.6x trailing earnings, cbdMD trades below the peer-group median of 12.6x. cbdMD's next earnings report is expected on Dec 18, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

About cbdMD

Company profile

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands.

Industry
Package Goods/Cosmetics
CEO
Mr. T. Ronan Kennedy
Headquarters
Charlotte, NC
Employees
42
IPO year
2017
Website
cbdmd.com

Financial highlights

Full financials

In fiscal 2025, cbdMD generated $19.2 million in revenue, down 1.5% from fiscal 2024, its first annual decline since 2024. cbdMD reported a net loss of $2.0 million, compared with a loss of $3.7 million a year earlier. Gross margin was 62.4% (up from 61.6%) and operating margin -11.3%.

cbdMD annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$19.19M$19.48M$24.16M$35.40M$44.48M
Growth-1.50%-19.35%-31.77%-20.41%+6.20%
Net income$-2.04M$-3.70M$-22.94M$-70.08M$-23.39M
EPS (diluted)$-1.09$-14.29$-13.32$-55.80$-0.47

Analyst forecast

Forecast

Consensus (1 analysts)

none

  • Strong buy 0
  • Buy 0
  • Hold 1
  • Sell 0
  • Strong sell 0

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Dec 18, 2026
Last reported (Q3 2026)
Aug 13, 2026
EPS actual vs est.
$-0.11 vs —

cbdMD peers

Consumer Discretionary sector
YCBD peer companies
CompanyPrice% ChgMarket capCompare
BIOTInstinct Bio Technical Company Holdings Inc.0.1432-12.15%$4.12Mvs YCBD
BNKKBonk Inc.0.4558-3.41%$3.91Mvs YCBD
CABRCaring Brands Inc.0.660.00%$7.59Mvs YCBD
BYAHPark Ha Biological Technology Co. Ltd. Class A0.8501-18.26%$16.59Mvs YCBD
AXILAXIL Brands Inc.4.27-5.22%$29.13Mvs YCBD
UGUnited-Guardian Inc.7.35+4.11%$33.77Mvs YCBD
WNWMeiwu Technology Company Limited1.65-13.42%$43.31Mvs YCBD
SLSNSolesence Inc.1.41-4.73%$99.61Mvs YCBD

Indexes, lists and sector

cbdMD stock FAQ

What is cbdMD's stock price today?

YCBD last traded at $0.36 as of Nov 20, 4:00 PM EST, down 5.11% on the day. Prices are delayed at least 15 minutes.

When is cbdMD's next earnings date?

cbdMD is expected to report earnings on Friday, December 18, 2026.

What is YCBD's P/E ratio?

YCBD trades at a trailing P/E ratio of 1.57, compared with a median of 12.6 for its closest peers.

Who is cbdMD's CEO?

Mr. T. Ronan Kennedy is the chief executive officer of cbdMD Inc., which has about 42 employees.

What is the YCBD 52-week high?

The 52-week high for YCBD is $2.56 and the 52-week low is $0.33. The stock is currently 85.9% below its high.

Compare YCBD